Synopsys, Inc. $SNPS Stock Position Cut by Aberdeen Group plc

Synopsys logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Aberdeen Group cut its Synopsys stake by 71.9% in the third quarter, selling 104,712 shares and ending the period with 40,991 shares valued at $17.8 million.
  • Synopsys reported quarterly EPS of $3.91 and revenue of $2.48 billion, beating analyst estimates; revenue grew 42.4% year over year. The board also approved a $1 billion share repurchase program.
  • Analyst sentiment was generally positive, with a consensus “Moderate Buy” rating and a $575 average price target. Company insiders sold about $51.4 million in stock over the past 90 days.
  • MarketBeat previews the top five stocks to own by December 1st.

Aberdeen Group plc reduced its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 71.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 40,991 shares of the semiconductor company's stock after selling 104,712 shares during the quarter. Aberdeen Group plc's holdings in Synopsys were worth $17,829,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in SNPS. BlackRock Inc. purchased a new stake in Synopsys in the second quarter worth about $7,228,099,000. Van ECK Associates Corp grew its holdings in Synopsys by 19.7% during the 2nd quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company's stock worth $1,542,175,000 after acquiring an additional 569,687 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Synopsys by 40.7% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,087,349 shares of the semiconductor company's stock valued at $1,377,174,000 after purchasing an additional 892,736 shares during the period. Assenagon Asset Management S.A. increased its position in Synopsys by 11.2% during the 3rd quarter. Assenagon Asset Management S.A. now owns 2,729,988 shares of the semiconductor company's stock valued at $1,187,381,000 after purchasing an additional 274,586 shares during the period. Finally, Amundi raised its holdings in shares of Synopsys by 3.6% in the 1st quarter. Amundi now owns 1,761,983 shares of the semiconductor company's stock valued at $698,591,000 after purchasing an additional 61,077 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.

Synopsys Stock Down 1.3%

Shares of NASDAQ SNPS opened at $435.51 on Wednesday. The company has a market capitalization of $83.46 billion, a P/E ratio of 44.85, a P/E/G ratio of 1.40 and a beta of 1.18. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. The company has a 50 day simple moving average of $446.98 and a 200-day simple moving average of $440.54. Synopsys, Inc. has a 1 year low of $362.55 and a 1 year high of $539.48.

Synopsys (NASDAQ:SNPS - Get Free Report) last posted its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, beating analysts' consensus estimates of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The company had revenue of $2.48 billion for the quarter, compared to the consensus estimate of $2.44 billion. During the same quarter in the previous year, the business earned $3.39 earnings per share. The company's revenue for the quarter was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, equities research analysts predict that Synopsys, Inc. will post 11.01 earnings per share for the current year.

Synopsys declared that its Board of Directors has approved a share buyback program on Monday, October 5th that authorizes the company to repurchase $1 billion in shares. This buyback authorization authorizes the semiconductor company to reacquire up to 1.1% of its shares through open market purchases. Share buyback programs are generally an indication that the company's board believes its shares are undervalued.

Insider Buying and Selling at Synopsys

In related news, CFO Sudhindra Kankanwadi sold 9,170 shares of Synopsys stock in a transaction on Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total value of $4,585,000.00. Following the completion of the transaction, the chief financial officer directly owned 22,717 shares in the company, valued at approximately $11,358,500. This trade represents a 28.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Sassine Ghazi sold 14,604 shares of the business's stock in a transaction on Thursday, October 15th. The stock was sold at an average price of $462.84, for a total value of $6,759,315.36. Following the transaction, the chief executive officer directly owned 76,865 shares of the company's stock, valued at $35,576,196.60. The trade was a 15.97% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 117,163 shares of company stock valued at $51,366,457 in the last 90 days. Corporate insiders own 0.56% of the company's stock.

Analyst Upgrades and Downgrades

SNPS has been the topic of several recent research reports. Zacks Research raised Synopsys from a "hold" rating to a "strong-buy" rating in a research report on Friday, October 2nd. BNP Paribas Exane boosted their price target on Synopsys from $420.00 to $475.00 and gave the stock a "neutral" rating in a research report on Thursday, October 1st. Rosenblatt Securities raised their price objective on Synopsys from $575.00 to $620.00 and gave the company a "buy" rating in a research report on Thursday, October 1st. Robert W. Baird upgraded Synopsys from a "neutral" rating to an "outperform" rating and lifted their target price for the company from $558.00 to $560.00 in a research note on Thursday, August 27th. Finally, Roth Capital upgraded Synopsys to a "buy" rating in a research note on Friday, September 25th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $575.00.

Read Our Latest Research Report on SNPS

About Synopsys

(Free Report)

Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.

Featured Articles

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines